LC‐MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study

Lu‐Ning Sun,Yang Zhao,Hua‐Ye Gao,Yan‐Ling Yang,Xu‐Ping Qian,Shi‐Yu Sun,Yu Wang,Li Ding,Yong‐Qing Wang
DOI: https://doi.org/10.1002/jssc.202200070
IF: 3.614
2022-05-22
Journal of Separation Science
Abstract:Pivmecillinam, the ester of biologically active antibiotic mecillinam, is an effective oral preparation to treat urinary tract infections. To study pharmacokinetics in humans, LC‐MS/MS methods were developed to quantify pivmecillinam and mecillinam in human plasma, respectively. Cephalexin as internal standards, analytes were separated on Ultimate®XB‐C18 columns after protein precipitation by acetonitrile. The mobile phase was composed of water containing 0.1% formic acid and methanol. The multiple reactions monitoring transitions of m/z 440.2→167.1, 326.1→167.1 and 348.1→158.1 were selected to inspect pivmecillinam, mecillinam and the internal standards in positive ion mode. No apparent matrix effect was perceived. Linearities were obtained over calibration ranges of 0.0500‐12.0 and 10.0‐15000 ng/mL, respectively. The intra‐day precisions were below 5.5%, the inter‐day precisions were below 6.1%, and accuracies got within ‐8.1% to 13.0%. Stability tests were conducted and an acidification step was explored to enhance the stability of pivmecillinam and mecillinam. Further stability was validated under various storage and processing conditions. Both methods were applied to a pharmacokinetic study of pivmecillinam and mecillinam after oral administration of 400 mg pivmecillinam hydrochloride tablets in healthy Chinese subjects. This article is protected by copyright. All rights reserved
chemistry, analytical
What problem does this paper attempt to address?